Skip to main content

Table 3 Immunoscore and Immunoprofiling differences

From: World-Wide Immunoscore Task Force: meeting report from the “Melanoma Bridge”, Napoli, November 30th–December 3rd, 2016

 

Immunoscore

Immunoprofiling

 

Prognostic/predictive (?)

Prognostic/predictive (?)

Number of Immunomarkers

2–4

1-several

Immunoscore markers

CD3/CD8 

Immune gene signatures

Immunoscore-like markers

CD3/CD8/CD20/FoxP3

Multiplex assays

CD3/CD8/CD45RO

CD137, Galectin1, LAG-3, OX40

PD-L1, TIM3 ect.

CD3/CD8/CD68

CD3/CD8/CD20

CD3/GZMB

CD8/FoxP3

CD8/IL17

(others)

Possible applications

• Staging in colorectal cancer (already tested)

• Prognostic assay

• Staging in melanoma, breast cancer, Ovarian cancer,  NSCLC, prostate cancer, pancreatic cancer, head and neck cancer (to be defined)

• Diagnostic assay

• Personalized immune-treatment